Reference list
- Lee, K. W., Okin, P. M., Kligfield, P., Stein, K. M., & Lerman, B. B.
(1997). Precordial QT dispersion and inducible ventricular
tachycardia. American heart journal, 134 (6), 1005-1013.
- Priori, S. G., Napolitano, C., Diehl, L., & Schwartz, P. J. (1994).
Dispersion of the QT interval. A marker of therapeutic efficacy in the
idiopathic long QT syndrome. Circulation, 89 (4), 1681-1689.
- Nousiainen, T., Jantunen, E., Vanninen, E., Remes, J., Puustinen, J.,
Rantala, A., . . . Hartikainen, J. (1998). Acute neurohumoral and
cardiovascular effects of idarubicin in leukemia patients.European journal of hematology, 61 (5), 347-353.
- Roden, D. M. (2008). Long-QT syndrome. New England Journal of
Medicine, 358 (2), 169-176.
- Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B.,
Fromer, M., . . Quinones, M. A. (2006). ACC/AHA/ESC 2006 guidelines
for management of patients with ventricular arrhythmias and the
prevention of sudden cardiac death—executive summary: a report of
the American College of Cardiology/American Heart Association Task
Force and the European Society of Cardiology Committee for Practice
Guidelines (Writing Committee to Develop Guidelines for Management of
Patients With Ventricular Arrhythmias and the Prevention of Sudden
Cardiac Death). Journal of the American College of Cardiology,
48 (5), 1064-1108.
- Day, C. P., McComb, J. M., & Campbell, R. W. (1990). QT dispersion:
an indication of arrhythmia risk in patients with long QT intervals.Heart, 63 (6), 342-344.
- Bovelli, D., Plataniotis, G., Roila, F., & Group, E. G. W. (2010).
Cardiotoxicity of chemotherapeutic agents and radiotherapy-related
heart disease: ESMO Clinical Practice Guidelines. Annals of
oncology, 21 (suppl_5), v277-v282.
- Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V.,
Asteggiano, R., Galderisi, M., . . . Lyon, A. R. (2016). 2016 ESC
Position Paper on cancer treatments and cardiovascular toxicity
developed under the auspices of the ESC Committee for Practice
Guidelines: The Task Force for cancer treatments and cardiovascular
toxicity of the European Society of Cardiology (ESC). European
heart journal, 37 (36), 2768-2801.
- Strevel, E. L., Ing, D. J., & Siu, L. L. (2007). Molecularly targeted
oncology therapeutics and prolongation of the QT interval.Journal of Clinical Oncology, 25 (22), 3362-3371.
- Shuykova, K. V., Storozhakov, G. I., Gendlin, G. E., & al., e.
(2010). The case of acute anthracyclines cardiotoxicity. In. Abstracts
of XXXIII World Congress of the ISH, Jerusalem, Israel.